New in science
Computational modeling in fight against corona virus
A 6-membered team from the Major group conducted a large benchmark study of ligand-protein docking methods to establish which work best for the main protease (Mpro) of SARS-CoV-2. This work, which is published in the Journal of Chemical Information and Modeling (American Chemical Society), will help researchers in academia and industry choose methods for new anti-viral design targeting coronaviruses. In this study, the researchers showed that the BIU-developed, ligand-protein docking software (EnzyDock) does very well for these systems, and better than most established methods in the field.
Israelische Startups: In Zukunft Augentropfen statt Brille
Audiatur Online (Switzerland) published a translation of a Israel 21c article on Nano-Drops, invented by Prof. Zeev Zalevsky, of the Kofkin Faculty of Engineering, Prof. Moshe Lellouche, of the Department of Chemistry and Institute for Nanotechnology and Advanced Materials (BINA), and Dr. David Smadja, a research associate at BINA.
Fim dos óculos? Experimento científico utiliza colírio com nanopartículas para corrigir miopia
Gizmodo Brazil published an article about Nano-Drops invented by Prof. Jean-Paul Lellouche, Chairman of the Department of Chemistry, Prof. Zeev Zalevsky, Vice Dean of the Alexander Kofkin Faculty of Engineering, and Dr. David Smadja, Research Associate at the Institute for Nanotechnology and Advanced Materials.
These nano eye drops could make glasses and contacts obsolete
The Week Magazine published an article about Nano-Drops invented by Prof. Jean-Paul Moshe Lellouche, of the Department of Chemistry, Prof. Zeev Zalevsky, Kofkin Faculty of Engineering, and Dr. David Smadja, of the Institute for Nanotechnology and Advanced Materials and Shaare Zedek Hospital.
Scientists learn to repair human bones by studying coral reefs
Nexus Media and Popular Science published articles about new research on corals conducted by Prof. Gil Goobes, of the Department of Chemistry, and team. The research was recently published in the scientific journal Nature Communications.
Nanodrug tames leishmaniasis and other parasitic diseases
Israel 21c published an article about a nanodrug developed by Vice President for Research Prof. Shulamit Michaeli and Prof. Jean-Paul (Moshe) Lellouche, Chairman of the Department of Chemistry and Institute for Nanotechnology and Advanced Materials (BINA), to treat Leishmaniasis, a disease of which there has recently been an outbreak in Israel. The Jewish Voice republished Israel 21c's article.
Ramat Gan, Israel — A revolutionary, cutting-edge technology, developed by researchers at Bar-Ilan University’s, has the potential to provide a new alternative to eyeglasses, contact lenses, and laser correction for refractive errors.
The technology, known as Nano-Drops, was developed by Dr. David Smadja (Ophthalmologist from Shaare Zedek Medical Center), Prof. Zeev Zalevsky, from Bar-Ilan’s Kofkin Faculty of Engineering, and Prof. Jean-Paul Moshe Lellouche, Head of the Department of Chemistry at Bar-Ilan.
Last Updated Date : 03/06/2021